CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial
The Stitch
MAY 21, 2024
The HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit. The post CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial appeared first on Baylor College of Medicine Blog Network.
Let's personalize your content